Folate receptor alpha is widely expressed and a potential therapeutic target in uterine and ovarian carcinosarcoma

Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium

S. Pecorelli · International Journal of Gynecology & Obstetrics · 2009 · 2.9K citations

Medicine, Gynecology, Oncology +10

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

Antonio C. Wolff, M. Elizabeth Hammond, Kimberly H. Allison et al. · Journal of Clinical Oncology · 2018 · 2.5K citations · Full text

Medicine, Oncology, Pathology +15

<i>HER2</i> Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology

Angela N. Bartley, M. Kay Washington, Carol Colasacco et al. · Journal of Clinical Oncology · 2017 · 434 citations

Medicine, Oncology, Pathology +14

Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study

Ursula A. Matulonis, Domenica Lorusso, Ana Oaknin et al. · Journal of Clinical Oncology · 2023 · 372 citations · Full text

Medicine, Oncology, Pharmacology +15

Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I

Kathleen N. Moore, Amit M. Oza, Nicoletta Colombo et al. · Annals of Oncology · 2021 · 292 citations · Full text

Medicine, Oncology, Pharmacology +16